C
CIN Terminal
Cannabis Investor News
A CanIDeal Company
All Insights
J

MSO Filing Flurry: Why Q4 Beats May Not Save 2026 Margins

A wave of SEC filings from Curaleaf, Trulieve, and Cronos reveals strong operational discipline — but macro headwinds and 280E pressure still weigh on forward estimates.

Key takeaways
    Share X LinkedIn Email
    Found this useful? Share it X LinkedIn

    More like this — straight to your inbox

    One new CIN Insight + the week's top three signals from the live terminal. Free, weekly.